Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase I/II results for Glaxo's tucaresol in metastatic melanoma

May 15, 1997

FDA approves Columbia's Crinone

May 15, 1997

Nippon Shinyaku characterizes novel sulfonamide antitumor agent

May 15, 1997

Pharmacokinetics and tissue distribution of TOP-53

May 15, 1997

Glutamate antagonists from Warner-Lambert

May 15, 1997

MS&D discloses 5-HT1-like receptor agonists

May 15, 1997

Antiischemic potassium channel activators described by BMS

May 15, 1997

3-D describes potent and selective thrombin inhibitors

May 15, 1997

Factor Xa inhibitors from 3-D

May 15, 1997

MS&D describes tachykinin antagonists

May 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...